Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Second Life Therapeutics
Novartis
University of Sunderland
University of Sunderland
University of Aarhus
Hoffmann-La Roche